Two leading cancer advocacy organisations engaged HTANALYSTS to understand the true impact of losing a parent to cancer, with a focus on parents of children under the age of 25.
Harnessing evidence to inform clinical practice and improve patient outcomes.
Every day, patient’s place their lives in the hands of medical and health professionals. To ensure safety and best outcomes, it is crucial that clinical practices are backed by the most up-to-date relevant evidence.
A leading pharmaceutical company with a novel disease-modifying product was seeking Government subsidy and wanted to better communicate the broader value of the drug, beyond the clinical measures captured through the clinical trial.